| negative regulation of gastrulation | GO:2000542 | 4 | 0.999 | |
| negative regulation of endodermal cell differentiation | GO:1903225 | 2 | 0.993 | |
| soft palate development | GO:0060023 | 3 | 0.988 | Human |
| regulation of endodermal cell differentiation | GO:1903224 | 3 | 0.983 | |
| embryonic skeletal joint development | GO:0072498 | 2 | 0.976 | Human |
| negative regulation of embryonic development | GO:0045992 | 4 | 0.974 | |
| formation of primary germ layer | GO:0001704 | 42 | 0.963 | |
| embryonic skeletal joint morphogenesis | GO:0060272 | 2 | 0.956 | Human |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.948 | |
| gastrulation | GO:0007369 | 51 | 0.941 | |
| angiogenesis involved in wound healing | GO:0060055 | 4 | 0.936 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.928 | |
| endodermal cell differentiation | GO:0035987 | 31 | 0.917 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.916 | Human |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.898 | |
| tube morphogenesis | GO:0035239 | 95 | 0.888 | |
| extracellular matrix organization | GO:0030198 | 41 | 0.881 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.868 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.868 | Human |
| response to growth factor | GO:0070848 | 205 | 0.858 | Human |
| biological adhesion | GO:0022610 | 331 | 0.850 | |
| regulation of cell migration | GO:0030334 | 289 | 0.846 | Human |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.826 | Human |
| circulatory system development | GO:0072359 | 262 | 0.801 | Human Mouse |
| digestive system development | GO:0055123 | 75 | 0.776 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.775 | Human |
| positive regulation of cell motility | GO:2000147 | 177 | 0.764 | Human |
| vascular wound healing | GO:0061042 | 4 | 0.759 | |
| sprouting angiogenesis | GO:0002040 | 29 | 0.756 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.755 | Human |
| cell adhesion | GO:0007155 | 325 | 0.730 | |
| regulation of locomotion | GO:0040012 | 329 | 0.728 | Human |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.727 | |
| vasculature development | GO:0001944 | 181 | 0.727 | Human Mouse |
| ameboidal type cell migration | GO:0001667 | 135 | 0.717 | |
| cell development | GO:0048468 | 328 | 0.713 | Human |
| tube development | GO:0035295 | 125 | 0.700 | |
| endoderm formation | GO:0001706 | 33 | 0.693 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.690 | |
| ossification | GO:0001503 | 121 | 0.673 | |
| angiogenesis | GO:0001525 | 147 | 0.665 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.651 | Human |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.649 | Human |
| mesenchyme development | GO:0060485 | 59 | 0.648 | Human |
| epithelium development | GO:0060429 | 227 | 0.642 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.636 | Human |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.631 | Human |
| regulation of cell differentiation | GO:0045595 | 393 | 0.621 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.618 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.618 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.614 | Human |
| blood vessel development | GO:0001568 | 172 | 0.614 | Human Mouse |
| regulation of cell motility | GO:2000145 | 299 | 0.612 | Human |
| digestive tract development | GO:0048565 | 75 | 0.609 | |
| bone development | GO:0060348 | 26 | 0.608 | |
| cardiovascular system development | GO:0072358 | 262 | 0.599 | Human Mouse |
| regulation of cellular component movement | GO:0051270 | 334 | 0.585 | Human |
| positive regulation of stem cell differentiation | GO:2000738 | 29 | 0.555 | Human |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.547 | Human |
| rho protein signal transduction | GO:0007266 | 26 | 0.537 | Human |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 33 | 0.530 | Human |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.530 | |
| organ morphogenesis | GO:0009887 | 147 | 0.526 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 94 | 0.510 | Human |
| cell morphogenesis | GO:0000902 | 296 | 0.493 | Human |
| skin development | GO:0043588 | 76 | 0.489 | |
| connective tissue development | GO:0061448 | 39 | 0.480 | Human Mouse |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.475 | Human |
| positive regulation of epithelial cell migration | GO:0010634 | 55 | 0.472 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.472 | |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.466 | |
| extracellular structure organization | GO:0043062 | 41 | 0.463 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.458 | Human |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 50 | 0.455 | Human |
| peptide cross linking | GO:0018149 | 12 | 0.437 | Human |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.431 | Human |
| stem cell development | GO:0048864 | 69 | 0.422 | Human |
| negative regulation of cell adhesion | GO:0007162 | 64 | 0.421 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 54 | 0.420 | Human |
| positive regulation of endothelial cell migration | GO:0010595 | 39 | 0.417 | |
| negative regulation of angiogenesis | GO:0016525 | 39 | 0.413 | |
| epithelial cell migration | GO:0010631 | 119 | 0.407 | |
| regulation of cell development | GO:0060284 | 161 | 0.407 | Human |
| endothelial cell proliferation | GO:0001935 | 65 | 0.405 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.403 | |
| multicellular organismal metabolic process | GO:0044236 | 34 | 0.399 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.389 | Human |
| ras protein signal transduction | GO:0007265 | 73 | 0.382 | Human |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.376 | |
| basement membrane organization | GO:0071711 | 3 | 0.371 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.369 | Human |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.367 | Human |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.366 | Human |
| regulation of angiogenesis | GO:0045765 | 92 | 0.363 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.360 | Human |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.358 | Human |
| negative regulation of cell migration | GO:0030336 | 102 | 0.357 | |
| growth | GO:0040007 | 202 | 0.353 | |
| heart development | GO:0007507 | 95 | 0.349 | Human Mouse |
| retina vasculature morphogenesis in camera type eye | GO:0061299 | 3 | 0.341 | |
| detection of mechanical stimulus involved in sensory perception of sound | GO:0050910 | 1 | 0.325 | Human |
| taxis | GO:0042330 | 157 | 0.322 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.321 | |
| embryo development | GO:0009790 | 123 | 0.317 | |
| cartilage development | GO:0051216 | 31 | 0.296 | Human |
| epithelium migration | GO:0090132 | 119 | 0.293 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 2 | 0.293 | |
| endothelial cell migration | GO:0043542 | 86 | 0.291 | |
| endoderm development | GO:0007492 | 33 | 0.290 | |
| response to wounding | GO:0009611 | 168 | 0.281 | |
| regulation of glomerulus development | GO:0090192 | 3 | 0.278 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.277 | |
| regulation of chemotaxis | GO:0050920 | 74 | 0.277 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.277 | |
| collagen metabolic process | GO:0032963 | 28 | 0.275 | |
| chemotaxis | GO:0006935 | 157 | 0.274 | |
| regulation of endothelial cell migration | GO:0010594 | 67 | 0.273 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 37 | 0.271 | Human |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.261 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.260 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 48 | 0.259 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.255 | |
| positive regulation of peptidyl tyrosine autophosphorylation | GO:1900086 | 1 | 0.252 | |
| positive regulation of vascular wound healing | GO:0035470 | 1 | 0.252 | |
| stem cell differentiation | GO:0048863 | 93 | 0.252 | Human |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.243 | Human |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.240 | |
| integrin biosynthetic process | GO:0045112 | 4 | 0.238 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.234 | |
| positive regulation of chemotaxis | GO:0050921 | 57 | 0.234 | |
| regulation of leukocyte chemotaxis | GO:0002688 | 46 | 0.231 | |
| muscle structure development | GO:0061061 | 98 | 0.231 | |
| regulation of vascular wound healing | GO:0061043 | 2 | 0.225 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.220 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.219 | |
| sensory organ morphogenesis | GO:0090596 | 21 | 0.218 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 1 | 0.216 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.214 | |
| tissue migration | GO:0090130 | 119 | 0.211 | |
| regulation of endothelial cell proliferation | GO:0001936 | 56 | 0.210 | |
| cellular response to amino acid stimulus | GO:0071230 | 12 | 0.209 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.207 | |
| epithelial to mesenchymal transition | GO:0001837 | 48 | 0.207 | Human |
| positive regulation of endothelial cell chemotaxis by vegf activated vascular endothelial growth factor receptor signaling pathway | GO:0038033 | 4 | 0.205 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 41 | 0.202 | |
| post embryonic development | GO:0009791 | 2 | 0.201 | |
| cell chemotaxis | GO:0060326 | 112 | 0.197 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.188 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.185 | Human |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 2 | 0.185 | |
| response to cytokine | GO:0034097 | 232 | 0.182 | Human |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.182 | Human |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 22 | 0.178 | Human |
| positive regulation of transport | GO:0051050 | 336 | 0.177 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.177 | |
| regulation of glomerular mesangial cell proliferation | GO:0072124 | 3 | 0.174 | |
| nervous system development | GO:0007399 | 293 | 0.174 | |
| patterning of blood vessels | GO:0001569 | 2 | 0.169 | |
| cell matrix adhesion | GO:0007160 | 85 | 0.168 | Human |
| cellular response to acid chemical | GO:0071229 | 44 | 0.166 | |
| visual perception | GO:0007601 | 27 | 0.166 | Human |
| biomineral tissue development | GO:0031214 | 39 | 0.165 | Human |
| activation of protein kinase activity | GO:0032147 | 90 | 0.164 | |
| negative regulation of phosphatidylinositol biosynthetic process | GO:0010512 | 2 | 0.162 | |
| skeletal system development | GO:0001501 | 79 | 0.156 | Human |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.155 | |
| blood circulation | GO:0008015 | 113 | 0.155 | Human |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 2 | 0.155 | |
| response to lipid | GO:0033993 | 206 | 0.155 | |
| collagen fibril organization | GO:0030199 | 10 | 0.154 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.152 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.151 | |
| glomerular mesangial cell proliferation | GO:0072110 | 3 | 0.151 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.150 | |
| regeneration | GO:0031099 | 4 | 0.150 | |
| embryonic organ development | GO:0048568 | 36 | 0.150 | Human |
| positive regulation of histone deacetylase activity | GO:1901727 | 3 | 0.149 | |
| regulation of mast cell chemotaxis | GO:0060753 | 4 | 0.149 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.146 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.146 | |
| cell projection organization | GO:0030030 | 252 | 0.145 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.144 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.143 | |
| positive regulation of mast cell chemotaxis | GO:0060754 | 4 | 0.139 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.138 | |
| wound healing | GO:0042060 | 115 | 0.138 | |
| endochondral bone morphogenesis | GO:0060350 | 3 | 0.136 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.136 | |
| positive regulation of fibroblast migration | GO:0010763 | 3 | 0.135 | |
| regulation of cell proliferation involved in kidney development | GO:1901722 | 3 | 0.133 | |
| plasma membrane organization | GO:0007009 | 115 | 0.131 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.130 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.129 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.129 | |
| detection of mechanical stimulus | GO:0050982 | 4 | 0.127 | Human |
| retina vasculature development in camera type eye | GO:0061298 | 3 | 0.125 | |
| cardiac muscle tissue development | GO:0048738 | 39 | 0.125 | |
| positive regulation of epithelial cell proliferation involved in wound healing | GO:0060054 | 3 | 0.125 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.124 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 76 | 0.124 | |
| detection of mechanical stimulus involved in sensory perception | GO:0050974 | 1 | 0.121 | Human |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.119 | |
| skeletal system morphogenesis | GO:0048705 | 24 | 0.119 | Human |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 26 | 0.118 | |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.118 | |
| regulation of behavior | GO:0050795 | 82 | 0.116 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.116 | |
| cyclic nucleotide metabolic process | GO:0009187 | 82 | 0.116 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.115 | Human |
| osteoblast differentiation | GO:0001649 | 92 | 0.113 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.113 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.112 | |
| morphogenesis of a branching epithelium | GO:0061138 | 20 | 0.112 | |
| extracellular fibril organization | GO:0043206 | 7 | 0.111 | |
| basophil chemotaxis | GO:0002575 | 1 | 0.109 | |
| immune response | GO:0006955 | 307 | 0.107 | Human |
| response to inorganic substance | GO:0010035 | 127 | 0.107 | |
| embryonic organ morphogenesis | GO:0048562 | 24 | 0.105 | Human |
| kidney development | GO:0001822 | 53 | 0.105 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.105 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.105 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.104 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.102 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.102 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 39 | 0.102 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.102 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.102 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.100 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.096 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.095 | Human |
| cell migration involved in kidney development | GO:0035787 | 2 | 0.094 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.093 | |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.093 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 41 | 0.093 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.092 | |
| segmentation | GO:0035282 | 4 | 0.091 | |
| response to acid chemical | GO:0001101 | 66 | 0.091 | |
| system process | GO:0003008 | 349 | 0.090 | Human |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.090 | |
| positive regulation of leukocyte chemotaxis | GO:0002690 | 38 | 0.090 | |
| regulation of cartilage development | GO:0061035 | 12 | 0.090 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.090 | |
| response to radiation | GO:0009314 | 151 | 0.090 | Human |
| canonical wnt signaling pathway involved in osteoblast differentiation | GO:0044339 | 2 | 0.090 | |
| response to hormone | GO:0009725 | 175 | 0.089 | |
| detection of abiotic stimulus | GO:0009582 | 15 | 0.089 | Human |
| metanephric nephron epithelium development | GO:0072243 | 4 | 0.087 | |
| mapk cascade | GO:0000165 | 288 | 0.086 | |
| positive regulation of cell migration involved in sprouting angiogenesis | GO:0090050 | 3 | 0.086 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.086 | |
| chordate embryonic development | GO:0043009 | 34 | 0.086 | Human |
| regulation of immune response | GO:0050776 | 201 | 0.084 | Human |
| bone trabecula formation | GO:0060346 | 1 | 0.084 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.084 | |
| negative regulation of vasculature development | GO:1901343 | 43 | 0.084 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.084 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.083 | Human |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.083 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.081 | |
| cytokine production | GO:0001816 | 247 | 0.080 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.079 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.078 | |
| regulation of leukocyte migration | GO:0002685 | 63 | 0.078 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.078 | |
| mucopolysaccharide metabolic process | GO:1903510 | 27 | 0.078 | |
| regulation of protein localization | GO:0032880 | 296 | 0.077 | |
| corticospinal tract morphogenesis | GO:0021957 | 1 | 0.077 | |
| protein localization to organelle | GO:0033365 | 280 | 0.077 | Human |
| regulation of cell substrate adhesion | GO:0010810 | 68 | 0.077 | |
| behavior | GO:0007610 | 112 | 0.076 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.076 | |
| amine metabolic process | GO:0009308 | 44 | 0.074 | |
| regulation of cell matrix adhesion | GO:0001952 | 42 | 0.074 | |
| sensory organ development | GO:0007423 | 52 | 0.073 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.073 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.073 | Human |
| embryonic skeletal system morphogenesis | GO:0048704 | 9 | 0.072 | Human |
| otic vesicle development | GO:0071599 | 1 | 0.071 | |
| regulation of axon guidance | GO:1902667 | 3 | 0.071 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.071 | |
| single organism membrane organization | GO:0044802 | 268 | 0.071 | |
| peptidyl serine modification | GO:0018209 | 106 | 0.070 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 29 | 0.070 | |
| regulation of blood pressure | GO:0008217 | 30 | 0.070 | Human |
| epiboly | GO:0090504 | 9 | 0.070 | |
| positive regulation of behavior | GO:0048520 | 60 | 0.069 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.069 | |
| tooth mineralization | GO:0034505 | 6 | 0.069 | Human |
| response to amino acid | GO:0043200 | 14 | 0.069 | |
| positive regulation of map kinase activity | GO:0043406 | 80 | 0.068 | |
| regulation of growth | GO:0040008 | 165 | 0.066 | |
| sensory perception of sound | GO:0007605 | 37 | 0.066 | Human |
| motor neuron axon guidance | GO:0008045 | 2 | 0.066 | |
| semicircular canal morphogenesis | GO:0048752 | 1 | 0.065 | |
| protein processing | GO:0016485 | 226 | 0.063 | |
| chromatin modification | GO:0016568 | 298 | 0.062 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.062 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.061 | |
| positive regulation of endothelial cell proliferation | GO:0001938 | 37 | 0.061 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.061 | |
| positive regulation of blood vessel endothelial cell migration | GO:0043536 | 16 | 0.061 | |
| regulation of histone deacetylase activity | GO:1901725 | 3 | 0.060 | |
| receptor internalization | GO:0031623 | 43 | 0.060 | |
| central nervous system development | GO:0007417 | 123 | 0.060 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.060 | |
| response to fibroblast growth factor | GO:0071774 | 39 | 0.059 | |
| head development | GO:0060322 | 108 | 0.059 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.059 | |
| protein maturation | GO:0051604 | 233 | 0.058 | |
| regulation of ossification | GO:0030278 | 58 | 0.058 | |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.058 | |
| neuron projection regeneration | GO:0031102 | 1 | 0.058 | |
| regulation of gastrulation | GO:0010470 | 12 | 0.058 | |
| urogenital system development | GO:0001655 | 65 | 0.058 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 63 | 0.058 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.057 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.057 | |
| response to drug | GO:0042493 | 81 | 0.057 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.057 | |
| negative regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043154 | 46 | 0.057 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.057 | |
| response to alcohol | GO:0097305 | 64 | 0.057 | |
| negative regulation of response to wounding | GO:1903035 | 47 | 0.056 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.056 | |
| proteoglycan metabolic process | GO:0006029 | 29 | 0.056 | |
| chromatin organization | GO:0006325 | 351 | 0.055 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 108 | 0.055 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 42 | 0.055 | |
| regulation of protein import into nucleus | GO:0042306 | 78 | 0.055 | |
| replacement ossification | GO:0036075 | 1 | 0.054 | |
| receptor metabolic process | GO:0043112 | 81 | 0.054 | |
| epiboly involved in wound healing | GO:0090505 | 8 | 0.054 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 85 | 0.053 | |
| cerebral cortex cell migration | GO:0021795 | 3 | 0.053 | |
| cartilage condensation | GO:0001502 | 1 | 0.053 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.052 | |
| glomerular basement membrane development | GO:0032836 | 3 | 0.052 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.051 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 2 | 0.050 | |
| regulation of cgmp metabolic process | GO:0030823 | 9 | 0.050 | |
| intracellular protein transport | GO:0006886 | 270 | 0.050 | |
| regulation of embryonic development | GO:0045995 | 20 | 0.050 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 55 | 0.050 | |
| leukocyte migration | GO:0050900 | 107 | 0.050 | |
| fibril organization | GO:0097435 | 10 | 0.050 | |
| granulocyte migration | GO:0097530 | 40 | 0.049 | |
| positive regulation of metanephros development | GO:0072216 | 3 | 0.049 | |
| wound healing spreading of cells | GO:0044319 | 8 | 0.049 | |
| peptidyl serine phosphorylation | GO:0018105 | 101 | 0.049 | |
| hindbrain development | GO:0030902 | 3 | 0.049 | |
| positive regulation of receptor internalization | GO:0002092 | 12 | 0.048 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.048 | |
| positive regulation of mesenchymal stem cell differentiation | GO:2000741 | 4 | 0.048 | |
| cell cell signaling | GO:0007267 | 155 | 0.047 | |
| odontogenesis | GO:0042476 | 25 | 0.047 | Human |
| cell substrate junction assembly | GO:0007044 | 35 | 0.047 | |
| histone modification | GO:0016570 | 251 | 0.047 | |
| positive regulation of keratinocyte migration | GO:0051549 | 4 | 0.047 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.046 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.046 | |
| axon regeneration | GO:0031103 | 1 | 0.046 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.046 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.045 | |
| regulation of blood coagulation | GO:0030193 | 42 | 0.045 | |
| endomembrane system organization | GO:0010256 | 196 | 0.045 | |
| positive regulation of glomerular mesangial cell proliferation | GO:0072126 | 1 | 0.045 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.044 | |
| negative regulation of axon guidance | GO:1902668 | 1 | 0.044 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.044 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.044 | |
| embryonic skeletal system development | GO:0048706 | 13 | 0.044 | Human |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.044 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.044 | |
| blood vessel endothelial cell migration | GO:0043534 | 42 | 0.044 | |
| regulation of axon extension involved in axon guidance | GO:0048841 | 2 | 0.043 | |
| regulation of nitric oxide mediated signal transduction | GO:0010749 | 2 | 0.043 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.043 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.043 | Human |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.042 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.042 | |
| protein deacetylation | GO:0006476 | 38 | 0.042 | |
| protein heterooligomerization | GO:0051291 | 16 | 0.042 | |
| salivary gland morphogenesis | GO:0007435 | 4 | 0.042 | |
| sensory perception of light stimulus | GO:0050953 | 35 | 0.042 | Human |
| zymogen activation | GO:0031638 | 70 | 0.041 | |
| regulation of sodium dependent phosphate transport | GO:2000118 | 2 | 0.041 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.041 | |
| response to steroid hormone | GO:0048545 | 80 | 0.041 | |
| endocytosis | GO:0006897 | 159 | 0.041 | |
| negative chemotaxis | GO:0050919 | 11 | 0.041 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.041 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.040 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.040 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.040 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.040 | |
| protein targeting | GO:0006605 | 187 | 0.040 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.040 | |
| negative regulation of immune response | GO:0050777 | 40 | 0.040 | Human |
| negative regulation of epithelial cell proliferation | GO:0050680 | 48 | 0.040 | |
| vascular process in circulatory system | GO:0003018 | 29 | 0.040 | |
| negative regulation of ectodermal cell fate specification | GO:0042666 | 1 | 0.040 | |
| negative regulation of epithelial cell migration | GO:0010633 | 38 | 0.039 | |
| endothelial cell cell adhesion | GO:0071603 | 1 | 0.039 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.039 | |
| glycoprotein metabolic process | GO:0009100 | 110 | 0.039 | |
| endothelial cell apoptotic process | GO:0072577 | 26 | 0.039 | |
| negative regulation of endopeptidase activity | GO:0010951 | 84 | 0.038 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.038 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 48 | 0.038 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.037 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.037 | |
| developmental growth | GO:0048589 | 48 | 0.036 | |
| generation of neurons | GO:0048699 | 152 | 0.036 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.036 | |
| cell migration involved in sprouting angiogenesis | GO:0002042 | 19 | 0.036 | |
| regulation of neuron differentiation | GO:0045664 | 70 | 0.036 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.036 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 19 | 0.036 | |
| regulation of receptor mediated endocytosis | GO:0048259 | 32 | 0.036 | |
| chondrocyte differentiation | GO:0002062 | 17 | 0.036 | |
| cell proliferation involved in kidney development | GO:0072111 | 3 | 0.036 | |
| regulation of protein transport | GO:0051223 | 213 | 0.035 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.035 | |
| positive regulation of glomerulus development | GO:0090193 | 1 | 0.035 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 4 | 0.035 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.035 | |
| brain development | GO:0007420 | 97 | 0.035 | |
| actin filament based process | GO:0030029 | 224 | 0.035 | |
| eye morphogenesis | GO:0048592 | 16 | 0.035 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.035 | |
| neurogenesis | GO:0022008 | 169 | 0.034 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.034 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 54 | 0.034 | |
| regulation of cell growth | GO:0001558 | 135 | 0.034 | |
| negative regulation of neurogenesis | GO:0050768 | 26 | 0.034 | |
| pattern specification process | GO:0007389 | 43 | 0.034 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.034 | |
| response to oxidative stress | GO:0006979 | 121 | 0.034 | |
| protein heterotrimerization | GO:0070208 | 4 | 0.034 | |
| regulation of blood vessel endothelial cell migration | GO:0043535 | 30 | 0.033 | |
| regulation of receptor internalization | GO:0002090 | 15 | 0.033 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.033 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.033 | |
| response to calcium ion | GO:0051592 | 46 | 0.033 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.033 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.032 | |
| response to peptide | GO:1901652 | 65 | 0.032 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.032 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.032 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.032 | |
| regulation of endothelial cell apoptotic process | GO:2000351 | 24 | 0.032 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.032 | |
| skin morphogenesis | GO:0043589 | 6 | 0.032 | Human |
| response to metal ion | GO:0010038 | 84 | 0.032 | |
| integrin mediated signaling pathway | GO:0007229 | 32 | 0.031 | Human |
| regulation of gtpase activity | GO:0043087 | 180 | 0.031 | |
| endothelial cell chemotaxis | GO:0035767 | 13 | 0.031 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.031 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.031 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.031 | |
| hemostasis | GO:0007599 | 76 | 0.031 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.031 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.031 | |
| response to bacterium | GO:0009617 | 144 | 0.031 | |
| secretion | GO:0046903 | 254 | 0.031 | |
| regulation of hemostasis | GO:1900046 | 42 | 0.031 | |
| aminoglycan metabolic process | GO:0006022 | 39 | 0.031 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.031 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.031 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.030 | |
| single organism cellular localization | GO:1902580 | 332 | 0.030 | |
| neuron differentiation | GO:0030182 | 138 | 0.030 | |
| immune system development | GO:0002520 | 195 | 0.030 | |
| cell growth | GO:0016049 | 160 | 0.030 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 24 | 0.030 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.030 | |
| chondrocyte development | GO:0002063 | 1 | 0.029 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.029 | |
| cgmp metabolic process | GO:0046068 | 19 | 0.029 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.029 | |
